This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Northwest University. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Xinfeng Zhao: Innovator in Cardiovascular Medicine
Introduction
Xinfeng Zhao is a notable inventor based in Xi'an, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating cardiovascular and cerebrovascular diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Xinfeng Zhao holds a patent for a compound titled "Substituted β-phenyl-α-hydroxy-propanoic acid, synthesis method and use thereof." This invention relates to a compound of the formula (I), where R, R', and R'' are each independently selected from H, OH, F, Cl, Br, methoxy, and ethoxy. The patent further details a process for synthesizing this compound and its application in the manufacture of a medicament for the prevention or treatment of cardiovascular or cerebrovascular diseases. He has 1 patent to his name.
Career Highlights
Xinfeng Zhao is affiliated with Northwest University, where he engages in research and development activities. His work is characterized by a strong focus on innovative solutions in the medical field, particularly concerning cardiovascular health. His contributions have been instrumental in advancing the understanding and treatment of related diseases.
Collaborations
Xinfeng Zhao has collaborated with notable colleagues, including Xiaohui Zheng and Qunzheng Zhang. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their respective fields.
Conclusion
Xinfeng Zhao's work exemplifies the impact of innovation in medicine, particularly in addressing critical health issues. His patent and ongoing research efforts contribute significantly to the advancement of treatments for cardiovascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
